Clindamycin
- Product NDC
- 52584-090
- 11-digit product format
- 525840090
- Labeler code
- 52584
- Product ID
- 52584-090_fd30c362-f7e7-4bb5-bedd-6d124ad0fd90
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Clindamycin Phosphate
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR; INTRAVENOUS
- Labeler
- General Injectables and Vaccines, Inc.
- Application
- ANDA090108
- Marketing category
- ANDA
- Marketing start
- 2019-08-30
- Marketing end
- 2023-06-30
- Substance
- CLINDAMYCIN PHOSPHATE
- Active strength
- 150 mg/mL
- Pharmacologic classes
- Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 52584-090-02 | 52584009002 | 1 VIAL in 1 BAG (52584-090-02) > 2 mL in 1 VIAL | 1 vial | 2019-09-10 | 0000-00-00 | No | No | Current |
| 52584-090-04 | 52584009004 | 1 VIAL in 1 BAG (52584-090-04) > 4 mL in 1 VIAL | 1 vial | 2019-08-30 | 0000-00-00 | No | No | Current |
| 52584-090-06 | 52584009006 | 1 VIAL, SINGLE-DOSE in 1 BAG (52584-090-06) > 6 mL in 1 VIAL, SINGLE-DOSE | | 2019-08-30 | 0000-00-00 | No | No | Current |